SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 459 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,235 | +10.2% | 2,900 | 0.0% | 0.04% | +14.7% |
| Q2 2023 | $558,134 | -4.9% | 2,900 | 0.0% | 0.03% | -10.5% |
| Q1 2023 | $587,163 | +57.6% | 2,900 | 0.0% | 0.04% | +52.0% |
| Q4 2022 | $372,679 | -6.1% | 2,900 | 0.0% | 0.02% | -13.8% |
| Q3 2022 | $397,000 | -22.6% | 2,900 | 0.0% | 0.03% | -19.4% |
| Q2 2022 | $513,000 | +22.7% | 2,900 | 0.0% | 0.04% | +50.0% |
| Q1 2022 | $418,000 | +42.2% | 2,900 | +52.6% | 0.02% | +33.3% |
| Q4 2021 | $294,000 | -9.0% | 1,900 | 0.0% | 0.02% | -18.2% |
| Q3 2021 | $323,000 | +7.7% | 1,900 | 0.0% | 0.02% | +10.0% |
| Q2 2021 | $300,000 | +13.6% | 1,900 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $264,000 | -53.0% | 1,900 | -40.8% | 0.02% | -57.4% |
| Q4 2020 | $562,000 | – | 3,209 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |